Pharmacokinetics of Different Pharmaceutical Nano Curcumin Products by Oral Administration

DOI:

https://doi.org/10.37285/ijpsn.2017.10.6.7

Authors

  • Bui Thanh Tung
  • Duong Thi Duyen
  • Hoang Thi Thuy
  • Ho Thi Hang
  • Karel Diéguez Santana
  • Maykel Cruz Monteagudo
  • Teresa Garrigues
  • Nguyen Thi Thanh Bin Bin
  • Nguyen Thanh Hai

Abstract

Curcumin has shown several potential pharmacological activities but it is limited on clinical application due to its poor bioavailability. Nano curcumin products have been investigated with purpose to increase curcumin’s bioavailability. Recently, for the first time, nanocurcumin was formulated in effervescent tablet (commercially available as SCurma FizzyTM). The aim of this study was to compare the pharmacokinetic parameters of this novel formulation of nanocurcumin and traditional formulation. In this study, the pharmacokinetic parameters of nanocurcumin in effervescent tablet, hard capsule and soft capsule in rats with a dose of 150 mg curcumin/kg body weight were investigated. The method to determine curcumin's concentration was validated and the concentration of curcumin in rat’s plasma was examined at pre-dose (0 min), 30, 60, 120, 150, 180 min after administration of curcumin. This data showed that the SCurma Fizzy tablet significantly improved the curcumin's concentration in plasma as compared with others products studied. In conclusion, the results suggested that effervescent tablet for nanoparticulate curcumin is recommended formulation to improve its bioavailability and therefore pharmacological activities.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Keywords:

Nanocurcumin, Oral absorption, Pharmacokinetics, Effervescent, Bioavailability

Downloads

Published

2017-11-30

How to Cite

1.
Tung BT, Duyen DT, Thuy HT, Hang HT, Santana KD, Monteagudo MC, et al. Pharmacokinetics of Different Pharmaceutical Nano Curcumin Products by Oral Administration. Scopus Indexed [Internet]. 2017 Nov. 30 [cited 2024 Dec. 21];10(6):3915-9. Available from: https://ijpsnonline.com/index.php/ijpsn/article/view/874

Issue

Vol. 10 No. 6 (2017): November-December 2017

Section

Research Articles
Crossref
Scopus
Google Scholar
Europe PMC

References

Bayomi, M. A., A. A. Al-Angary, M. A. Al-Meshal and M. M. Al-Dardiri (1998). In vivo evaluation of arteether liposomes. International Journal of Pharmaceutics 175(1): 1-7.
Gursoy, R. N. and S. Benita (2004). Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. Biomedicine & Pharmacotherapy 58(3): 173-182.
Hassaninasab, A., Y. Hashimoto, K. Tomita-Yokotani and M. Kobayashi (2011). Discovery of the curcumin metabolic pathway involving a unique enzyme in an intestinal microorganism. Proceedings of the National Academy of Sciences 108(16): 6615-6620.
Hatcher, H., R. Planalp, J. Cho, F. Torti and S. Torti (2008). Curcumin: from ancient medicine to current clinical trials. Cellular and Molecular Life Sciences 65(11): 1631-1652.
Hussain, N., V. Jaitley and A. T. Florence (2001). Recent advances in the understanding of uptake of microparticulates across the gastrointestinal lymphatics. Advanced Drug Delivery Reviews 50(1): 107-142.
Lao, C. D., M. T. Ruffin, D. Normolle, D. D. Heath, S. I. Murray, J. M. Bailey, M. E. Boggs, J. Crowell, C. L. Rock and D. E. Brenner (2006). Dose escalation of a curcuminoid formulation. BMC complementary and alternative medicine 6(1): 10.
Lim, S.-J., M.-K. Lee and C.-K. Kim (2004). Altered chemical and biological activities of all-trans retinoic acid incorporated in solid lipid nanoparticle powders. Journal of Controlled Release 100(1): 53-61.
Ma, Z., A. Shayeganpour, D. R. Brocks, A. Lavasanifar and J. Samuel (2007). High‐performance liquid chromatography analysis of curcumin in rat plasma: application to pharmaco-kinetics of polymeric micellar formulation of curcumin. Biomedical Chromatography 21(5): 546-552.
Maiti, K., K. Mukherjee, A. Gantait, B. P. Saha and P. K. Mukherjee (2007). Curcumin–phospholipid complex: preparation, therapeutic evaluation and pharmacokinetic study in rats. International Journal of Pharmaceutics 330(1): 155-163.
Pang, K. S. (2003). Modeling of intestinal drug absorption: roles of transporters and metabolic enzymes (for the Gillette Review Series). Drug Metabolism and Disposition 31(12): 1507-1519.
Ravichandran, R. (2013). Pharmacokinetic study of nanoparticulate curcumin: oral formulation for enhanced bioavailability. Journal of Biomaterials and Nanobiotechnology 4(03): 291.
Setthacheewakul, S., S. Mahattanadul, N. Phadoongsombut, W. Pichayakorn and R. Wiwattanapatapee (2010). Development and evaluation of self-microemulsifying liquid and pellet formulations of curcumin, and absorption studies in rats. European Journal of Pharmaceutics and Biopharmaceutics 76(3): 475-485.
Shaikh, J., D. Ankola, V. Beniwal, D. Singh and M. R. Kumar (2009). Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer. European Journal of Pharmaceutical Sciences 37(3): 223-230.
Singh, B. N. and K. H. Kim (2000). Floating drug delivery systems: an approach to oral controlled drug delivery via gastric retention. Journal of Controlled Release 63(3): 235-259.
Stuart, D. and T. Allen (2000). A new liposomal formulation for antisense oligodeoxynucleotides with small size, high incorporation efficiency and good stability. Biochimica et Biophysica Acta (BBA)-Biomembranes 1463(2): 219-229.
Yuan, H., J. Chen, Y.-Z. Du, F.-Q. Hu, S. Zeng and H.-L. Zhao (2007). Studies on oral absorption of stearic acid SLN by a novel fluorometric method. Colloids and Surfaces B: Biointerfaces 58(2): 157-164.
Zhang, Y., M. Huo, J. Zhou and S. Xie (2010). PKSolver: An add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel. Computer Methods and Programs in biomedicine 99(3): 306-314.